-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Rocket Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q2 2025.
- Rocket Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 111M shares, a 18.4% increase year-over-year.
- Rocket Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 94.8M shares, a 12.9% increase from 2023.
- Rocket Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 84M shares, a 23.3% increase from 2022.
- Rocket Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 68.1M shares, a 7.77% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)